We searched Medline, CINAHL, and Cochrane
reduce the morbidity and mortality of patients undergoing major surgery or patients with septic shock as it allows implementation of early goal-directed therapies (EGDT). [12] [13] [14] This is an update of a previously published AARC Clinical Practice Guideline (CPG) from 2001 15 . The recommendations provided in this CPG are based on a search of Medline, CINAHL, and Cochrane Library database for articles published between January 1990 and December 2012.
The update of this clinical practice guideline is based on 237 clinical trials, 54 reviews and 23 meta-analyses on Blood Gas Analysis (BGA) and Hemoximetry
BGA 2.0 SETTING:
Blood gas analysis should be performed by trained individuals 16, 17 in a variety of settings including, but not limited to:
hospital laboratories,

hospital emergency departments,
patient-care areas,
clinic laboratories,
2.5 laboratories in physicians' offices. 16 2.6 interfacility critical care transports. 1, 6, 7 and intrapulmonary shunt (Q sp /Q t ); 3.1.2 the need to quantify the response to therapeutic intervention (e.g., supplemental oxygen administration, mechanical ventilation) or diagnostic evaluations (e.g., exercise desaturation); 4, 6, 7, 22 3.1.3 the need to assess early goal-directed therapy (EGDP) measuring ScvO 2 in patients with sepsis, septic shock and after major surgery. 3.1.5 the need to assess inadequacy of circulatory response.
A high central venous -arterial PCO2 gradient can indicate inadequate
perfusion as observed in severe hemorrhagic shock, poor cardiac output, during cardiopulmonary resuscitation, and after cardiopulmonary bypass. [24] [25] [26] [27] [28] 3.1.6 the need to assess acid-base status when an arterial blood gas cannot be obtained. 
BGA 4.0 CONTRAINDICATIONS:
Contraindications to performing pH-blood gas analysis and hemoximetry include:
4.1 an improperly functioning blood gas analyzer;
4.2 a blood gas analyzer that has not had functional status validated through: at 37 º C must also be reported. 3 It should be noted that there is no data currently available that can quantify the balance between oxygen delivery and oxygen demand at temperatures other than 37oC and that temperature correction of blood gas samples is not recommended 63 .
6.1.10 hemodilution or altered osmolality when measuring hematocrit using conductometry sensor technology 1, 52 .
6.1.11 high speed transport tube systems, which may produce erroneous PO2 results 64 .
Specifically, samples with a PO2 above that of ambient air may be underestimated and those with a PO2 below that of ambient air may overestimated. Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE. Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE.
6.5.4
The presence of a high central venous -arterial PCO2 gradient helps identifying inadequacy of circulatory response as the one present in severe hemorrhagic shock, poor cardiac output, during cardiopulmonary resuscitation, and after cardiopulmonary bypass.
24-28
BGA 7.0 ASSESSMENT OF NEED:
The presence of a valid indication (BGA 3.0) in the subject to be tested supports the need for sampling and analysis. Results of BGA should either a) help diagnose or confirm the presence of a disease or b) potentially alter patient treatment.
BGA 8.0 ASSESSMENT OF QUALITY OF TEST AND VALIDITY OF RESULTS:
The consensus of the committee is that all diagnostic procedures should follow the quality model described in the NCCLS GP26 A Quality System Model for Health Care. 75 The document describes a laboratory path of workflow model that incorporates all the steps of the procedure.
This process begins with patient assessment and the generation of a clinical indication for testing through the application of the test results to patient care. The quality system essentials defined for all healthcare services provide the framework for managing the path of workflow. A continuation of this model for respiratory care services is further described in NCCLS HS4-A A Quality System Model for Respiratory Care. 76 . In both quality models the patient is the central focus.
General considerations include:
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Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE. 79 but unless the entire tonometry process is of the highest quality, it, too, can have errors.
8.3.3.3
When an existing instrument is replaced, duplicate analysis must be performed to compare the new instrument to the existing instrument.
Calibration verification 80
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8.4
Testing (analytical phase) is carried out according to an established proven protocol, conforming to manufacturer recommendations; 3, 38 The following aspects of analysis should be monitored and corrective action taken as indicated: 
8.5
Post-testing (post-analytical phase); The results should validate or contradict the patient's clinical condition (i.e., the basis for ordering the test).
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Documentation of results, therapeutic intervention (or lack of)
, and/or clinical decisions based upon the pH-blood gas measurements should be available in the patient's medical record and/or be otherwise readily accessible (e.g., at the testing area) for at least 2 years. Federal regulations 16 stipulate that requirements relative to personnel (levels of education and training), documentation procedures and equipment be fulfilled. Blood gas instrumentation is classified as being either moderately or highly complex. Persons performing blood gas analysis should be conversant with applicable federal regulations (CLIA'04) 16 and appropriately qualified.
In addition to federal regulations, state regulatory requirements for blood gas analysis must also be met.
Recommended Equipment:
9.1.1 Automated or semi-automated pH-blood gas analyzer with related calibration gases, electrodes, membranes, electrolytes, reagents, and accessories. 3, 16, 38 9.1.2 Fixed, multiple wavelength spectrophotometer (hemoximeter or CO-oximeter) 32 or other device for determining total hemoglobin and its components. Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE.
9.1.4
Quality control and proficiency testing materials.
Personnel:
The following recommendations are for tests of moderate complexity, as designated by CLIA. 16 Persons at either of the levels described should perform pH-blood gas analysis under the direction and responsibility of a laboratory director and technical consultant (may be the same individual) who possess at least a baccalaureate degree and who have specific training in blood gas analysis and interpretation. Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE. 
BGA 10.0 MONITORING:
Monitoring of personnel, sample handling, and analyzer performance to assure proper handling, analysis, and reporting should be ongoing, during the process.
BGA 11.0 FREQUENCY:
Frequency of execution of quality control maneuvers depends upon the sample load of the laboratory and the requirements of agencies that specify those maneuvers.
BGA 12.0 INFECTION CONTROL:
BGA 13.0 AGE-SPECIFIC ISSUES:
This document applies to samples from neonatal, pediatric, adult, and geriatric populations.
BGA 14.0 RECOMMENDATIONS
The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. 
